Home Tools
Log in
Cart

Search Result

Search Results for " malignancy "

20

Compounds

Cat No. Product Name Synonyms Targets
T13176 TNO155 Batoprotafib Phosphatase
TNO155 is a protein tyrosine phosphatase (PTP) non-receptor type 11 (SHP2; src homology region 2 domain phosphatase; PTPN11) inhibitor(IC50 : 0.011 µM),with potential antineoplastic activity.
T8958 PU-H54 GPR
PU-H54 is a purine-based inhibitor of Grp94. It is a Grp94-selective resorcinol-based inhibitor isolated through probing of the exclusive binding region of S2 subpocket in Grp94.
T9756 AZD-9574 PARP
AZD-9574 is a selective inhibitor of PARP1 at the sites of SSBs. AZD-9574 exhibits anti-cancer activities and can be used in studies about HRD+ breast cancer and advanced solid malignancies.
T21505 Suberoyl bis-hydroxamic acid SBHA,Suberohydroxamic acid Apoptosis , HDAC
Suberoyl bis-hydroxamic acid (SBHA) is a Histone deacetylase (HDAC) inhibitor. HDAC is required for transcriptional modulation, cell cycle regulation and development. It is an enzyme that deacetylates lysine residues on ...
TN2064 Physcion 8-O-β-D-glucopyranoside Physcion 8-O-beta-D-monoglucoside TNF
Physcion 8-O-β-D-glucopyranoside (Physcion 8-O-beta-D-monoglucoside) has anti-inflammatory and anti-cancer activities. Physcion 8-O-β-D-glucopyranoside can be used in studies about common malignancy cancer.
T60152 AZ5576 CDK
AZ5576 is a potent and highly selective CDK9 inhibitor. AZ5576 can be used for the research of Hematological Malignancy [1].
T19461 N1,N8-Diacetylspermidine Endogenous Metabolite
N1,N8-Diacetylspermidine is a polyamine found in human urine.N1,N8-Diacetylspermidine can be used as a marker for cancer and malignancy.
T6739 Zoledronic Acid CGP-4244,CGP42446A,Zoledronate,CGP 42446,ZOL 446,Zometa Apoptosis , Rho , Autophagy
Zoledronic Acid (ZOL 446) is a bisphosphonate. Zoledronic Acid (ZOL 446) is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer. It can also be used to treat hypercalc...
T6960L PU-H71 HCl PU-H71 HCl(873436-91-0 Free base),Zelavespib HCl HSP , DNA/RNA Synthesis
PU-H71 HCl (Zelavespib HCl) is a novel Hsp90 inhibitor, a novel purine-based analog, and a radiosensitizer that may be a promising agent for CIRT. PU-H71 HCL shows antitumor activity in many preclinical models of maligna...
T28143 ND-2110 ND2110
ND-2110, a selective interleukin-1 receptor-associated kinase 4 inhibitors, is used for the treatment of autoimmune disorders and lymphoid malignancy.
T64310 KUSC-5001
KUSC-5001 is a potent inhibitor (IC50: 18 μM) of HIF-1, which has a key role in tumour survival and malignancy.
T70677 PLS-123
PLS-123 is a novel covalent irreversible Btk inhibitor with potential anti-proliferative activity. PLS-123 exhibited more potent anti-proliferative effects than ibrutinib in multiple cellular and in vivo preclinical mode...
T63221 PI3Kδ/γ-IN-2
PI3Kδ/γ-IN-2 is a potent, orally bioavailable dual inhibitor of PI3Kδ (IC50: 1 nM) and PI3Kγ (IC50: 4.3 nM) with potential for use in anti-B-cell malignancy studies.
T9922 Matuzumab EGFR
Matuzumab is a humanized monoclonal antibody used in cancer treatment. It has a high affinity for EGFR frequently associated with the growth of blood vessels in malignancy facilitating tumor growth and survival.
T81351 PTH-Related Protein (1-34) amide (human, mouse, rat) Human PTHrP-(1-34)NH2
Human PTHrP-(1-34)NH2, also known as PTH-Related Protein (1-34) amide for human, mouse, and rat, is the N-terminal fragment of PTHrP. This peptide induces hypercalcemia and is utilized in the study of humoral hypercalcem...
T83219 ABBV-467
ABBV-467, a selective MCL-1 inhibitor (K i : <0.01 nM), induces apoptosis and effectively promotes cancer cell death while inhibiting tumor growth in hematological malignancy models, including multiple myeloma [1].
T77990 Human PTHrP-(1-36)
Human PTHrP-(1-36) is a secreted form of parathyroid hormone-related protein that exhibits anticalciuric effects and promotes beta cell function and proliferation. It is utilized in research pertaining to humoral hyperca...
T62408 PI3Kδ-IN-11
PI3Kδ-IN-11 is a potent and selective PI3Kδ inhibitor (IC50: 27.5 nM) that dose-dependently blocks PI3K/Akt pathway activity. PI3Kδ-IN-11 can be used in B- or T-cell-associated malignancy studies.
T73132 DS69910557
DS69910557, a potent, selective, and orally active antagonist of the human parathyroid hormone receptor 1 (hPTHR1), exhibits antagonistic activity with an IC50 value of 0.08 μM. It is useful in researching hyperparathyro...
T75670 Lacto-N-fucopentaose II
Lacto-N-fucopentaose II (LNFP II), a sialyl-Lewis hapten of the human Lewis blood group determinant, serves as a monosialo-ganglioside/glycolipid and sialyl derivative, CA 19-9. It is recognized as a molecular tumor mark...
1 2
TargetMol